Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy
出版年份 2014 全文链接
标题
Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume 10, Issue 2, Pages 207-217
出版商
Informa UK Limited
发表日期
2014-01-13
DOI
10.1586/1744666x.2014.875856
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cutting Edge: CD4+ T Cell-Derived IL-2 Is Essential for Help-Dependent Primary CD8+ T Cell Responses
- (2014) E. B. Wilson et al. JOURNAL OF IMMUNOLOGY
- Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
- (2013) J. D. Wolchok et al. ANNALS OF ONCOLOGY
- Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival
- (2013) Richard K. Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Prolonged Survival of Allogeneic Islets in Cynomolgus Monkeys After Short-Term Triple Therapy
- (2012) M. Koulmanda et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
- (2012) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Immunotherapy in Type 1 Diabetes: A Shorter but More Winding Road?
- (2012) E. Bonifacio DIABETES
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: A versatile platform for fine epitope mapping
- (2012) Gertrudis Rojas et al. IMMUNOBIOLOGY
- Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy
- (2012) Scott A. Gerber et al. IMMUNOLOGY
- Effects of an agonist interleukin-2/Fc fusion protein, a mutant antagonist interleukin-15/Fc fusion protein, and sirolimus on cardiac allograft survival in non-human primates
- (2012) Timothy Millington et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Transient Enhanced IL-2R Signaling Early during Priming Rapidly Amplifies Development of Functional CD8 + T Effector-Memory Cells
- (2012) Iris Castro et al. JOURNAL OF IMMUNOLOGY
- Intratumoral hu14.18-IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention
- (2012) R. K. Yang et al. JOURNAL OF IMMUNOLOGY
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
- (2012) Aaron M Ring et al. NATURE IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating Human Autoimmunity: Current Practice and Future Prospects
- (2012) M. D. Rosenblum et al. Science Translational Medicine
- Selectively Expanding Subsets of T Cells in Mice by Injection of Interleukin-2/Antibody Complexes: Implications for Transplantation Tolerance
- (2012) O. Boyman et al. TRANSPLANTATION PROCEEDINGS
- Application of IL-2 therapy to target T regulatory cell function
- (2012) Ethan M. Shevach TRENDS IN IMMUNOLOGY
- Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma
- (2012) Tony A. Koehn et al. Frontiers in Pharmacology
- Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface
- (2011) Jennifer A. A. Gubbels et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Low-Toxicity IL-2-Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
- (2011) S. D. Gillies et al. CLINICAL CANCER RESEARCH
- Central Role for Interleukin-2 in Type 1 Diabetes
- (2011) M. A. Hulme et al. DIABETES
- Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
- (2011) John Puskas et al. IMMUNOLOGY
- Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells
- (2011) Jonathan Sprent et al. NATURE IMMUNOLOGY
- The Yin and Yang of Interleukin-2–Mediated Immunotherapy
- (2011) Jeffrey A. Bluestone NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
- (2010) D. C. Delgado et al. CANCER RESEARCH
- Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
- (2010) Dan R. Littman et al. CELL
- Prolonged Interleukin-2Rα Expression on Virus-Specific CD8+ T Cells Favors Terminal-Effector Differentiation In Vivo
- (2010) Vandana Kalia et al. IMMUNITY
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
- (2010) Matthew E. Pipkin et al. IMMUNITY
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
- (2010) Thomas R. Malek et al. IMMUNITY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-2 Complex Treatment Can Protect Naive Mice from Bacterial and Viral Infection
- (2010) S. E. Hamilton et al. JOURNAL OF IMMUNOLOGY
- IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor subunit CD25
- (2010) S. Letourneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells
- (2010) C. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacologic Administration of Interleukin-2
- (2009) Antonio Romo de Vivar Chavez et al. Annals of the New York Academy of Sciences
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy
- (2009) J. Tomala et al. JOURNAL OF IMMUNOLOGY
- Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma
- (2009) Antoni Ribas et al. Journal of Translational Medicine
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
- Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target
- (2008) Dorothy K. Sojka et al. IMMUNOLOGY
- Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation
- (2008) G.-H. Jin et al. INTERNATIONAL IMMUNOLOGY
- Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy
- (2008) Mohamed A. Shaker et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
- (2008) G. Verdeil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Biology of Shared Cytokine Receptors
- (2007) Xinquan Wang et al. Annual Review of Immunology
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search